Management of Acremonium Peritonitis in Peritoneal Dialysis
Remove the peritoneal dialysis catheter immediately and initiate systemic antifungal therapy with voriconazole as first-line treatment. 1
Immediate Actions
Catheter removal is mandatory and should be performed promptly upon diagnosis - this is almost always necessary for successful treatment of fungal peritonitis, including Acremonium species. 1 Unlike bacterial peritonitis where catheter salvage may be attempted, fungal peritonitis requires definitive catheter removal because systemic antifungal therapy alone yields inconsistent results. 2
- Remove the catheter as soon as the diagnosis is established, ideally within the first few days of presentation. 1, 2
- Do not delay catheter removal hoping for medical management alone - this approach has historically failed in Acremonium peritonitis cases. 3, 2
Antifungal Therapy Selection
Start voriconazole immediately as first-line systemic antifungal therapy upon diagnosis or strong clinical suspicion of Acremonium peritonitis. 1 This recommendation comes from the International Society of Peritoneal Dialysis and Infectious Diseases Society of America guidelines.
Alternative agents if voriconazole is contraindicated or unavailable:
- Amphotericin B (lipid formulation preferred at 3-5 mg/kg daily) 1
- Posaconazole as a second alternative 1
Important considerations about Acremonium susceptibility:
- Acremonium species demonstrate variable and often poor in vitro susceptibility to most antifungal agents, with high MICs documented for many standard therapies. 1
- This underscores why catheter removal is non-negotiable - medical therapy alone is insufficient. 1, 2
Treatment Duration and Timing
Continue systemic antifungal therapy for 2-3 weeks, guided by clinical response. 1 The treatment timeline should follow this sequence:
- Initiate antifungals immediately (ideally within 3-4 days of presentation) 4
- Remove catheter promptly upon diagnosis 1, 2
- Wait at least 2 weeks after catheter removal before considering placement of a new catheter to allow adequate treatment and resolution of infection 1
- Total antifungal duration: 2-3 weeks from catheter removal, adjusted based on clinical response 1
Monitoring for treatment response:
- Clearing of dialysate effluent 1
- Resolution of abdominal pain 1
- Normalization of inflammatory markers 1
Critical Pitfalls to Avoid
Do not rely on early negative cultures - Acremonium grows slowly in culture, and plates must be incubated for at least 2 weeks to avoid false-negative results. 1 If clinical suspicion is high based on cloudy effluent and symptoms, proceed with catheter removal even if initial cultures are negative.
Avoid aminoglycosides if any residual renal function exists - these agents cause nephrotoxicity and will compromise residual kidney function, which is crucial for patient outcomes and potential return to peritoneal dialysis. 1
Do not attempt catheter salvage strategies - while one case report described experimental use of in-situ lyticase enzyme during the COVID-19 pandemic when catheter removal was delayed 5, this is not standard practice and should only be considered in extraordinary circumstances where catheter removal is impossible.
Special Considerations for High-Risk Patients
For immunocompromised or critically ill patients, the same aggressive approach applies but with heightened urgency:
- These patients have higher mortality risk with fungal peritonitis (exceeding 50% in some series) 1
- Antifungal therapy is particularly critical in this population 6
- Consider more intensive monitoring and potentially longer antifungal courses 1
Surgical Considerations Beyond Catheter Removal
Evaluate for extension of infection beyond the peritoneum - if there is evidence of osteomyelitis, septic arthritis, or progressive infection despite medical therapy, surgical debridement of infected tissue may be necessary. 1
Return to Peritoneal Dialysis
After successful treatment:
- Minimum 2-week waiting period after catheter removal before placing new catheter 1
- Ensure complete resolution of symptoms and normalization of inflammatory markers before catheter replacement 1
- Some patients may require permanent transition to hemodialysis if peritoneal membrane function is compromised 4